ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

DMK DMK Pharmaceuticals Corporation

0.232
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
DMK Pharmaceuticals Corporation DMK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.232 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.232
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/3/202413:23EDGAR2Form 25-NSE - Notification filed by national security..
07/2/202416:19EDGAR2Form 8-K - Current report
06/2/202409:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202408:00EDGAR2Form 8-K - Current report
31/1/202416:17EDGAR2Form 8-K - Current report
23/1/202416:23EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202416:22EDGAR2Form 8-K - Current report
03/1/202416:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/1/202416:02EDGAR2Form 8-K - Current report
03/1/202416:00EDGAR2Form 8-K - Current report
21/12/202311:31EDGAR2Form 8-K - Current report
21/12/202307:15GLOBEDMK Pharmaceuticals Regains Full Rights to Commercialize..
04/12/202315:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/12/202315:45EDGAR2Form 8-K - Current report
28/11/202315:41EDGAR2Form 8-K - Current report
28/11/202307:05GLOBEDMK Pharmaceuticals Regains Full Rights from US WorldMeds..
15/11/202315:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/11/202315:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/11/202315:11EDGAR2Form 8-K - Current report
15/11/202315:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/11/202314:57EDGAR2Form 8-K - Current report
14/11/202306:30GLOBEDMK Pharmaceuticals Reports Third Quarter 2023 Financial..
13/11/202309:52GLOBEDMK Pharmaceuticals Announces Presentation of Preclinical..
02/11/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202315:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202306:30GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
25/10/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202316:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/10/202315:15GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
19/10/202316:07EDGAR2Form 8-K - Current report
19/10/202315:05GLOBEDMK Pharmaceuticals Restructures Executive Team to Support..
17/10/202315:37EDGAR2Form 8-K - Current report
17/10/202311:28EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
12/10/202315:22EDGAR2Form DEFC14A - Definitive proxy statement, contested..
10/10/202305:01EDGAR2Form 8-K - Current report
02/10/202315:49EDGAR2Form PREC14A - Preliminary proxy statements, contested..
26/9/202307:37EDGAR2Form SC 13D/A - General statement of acquisition of..
19/9/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202311:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..

Su Consulta Reciente

Delayed Upgrade Clock